Oxidation state specific analysis of arsenic species in tissues of wild-type and arsenic (+ 3 oxidation state) methyltransferase-knockout mice

Journal of Environmental Sciences (China)

Volumn 49, Issue , 2016, Pages 104-112

  Currier, Jenna M ^a   Douillet, Christelle ^b   Drobná, Zuzana ^b   Stýblo, Miroslav ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina   (United States)

Author keywords

Arsenic (+ 3 oxidation state) methyltransferase; Arsenic speciation analysis; As3mt knockout mice; Hydride generation cryotrapping atomic absorption spectrometry

Indexed keywords

ABSORPTION SPECTROSCOPY; ALKYLATION; ARSENIC; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; HISTOLOGY; OXIDATION; POTABLE WATER; TISSUE;

ARSENIC SPECIATION ANALYSIS; ARSENIC SPECIES; CRYOTRAPPING; INORGANIC ARSENIC; INTESTINAL BACTERIA; KNOCKOUT MICE; METHYLTRANSFERASES; OXIDATION STATE;

MAMMALS;

ARSENIC; ATOMIC ABSORPTION SPECTROSCOPY; CATALYSIS; METABOLITE; OXIDATION; RODENT; SPECIATION (CHEMISTRY);

MUS;

ARSENIC; METHYLTRANSFERASE; ORGANOARSENIC DERIVATIVE; WATER POLLUTANT;

ANIMAL; C57BL MOUSE; MALE; MOUSE; OXIDATION REDUCTION REACTION; TOXICITY; WATER POLLUTANT;

ANIMALS; ARSENIC; ARSENICALS; MALE; METHYLTRANSFERASES; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; WATER POLLUTANTS, CHEMICAL;

EID: 84995665679     PISSN: 10010742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jes.2016.06.018     Document Type: Article

References (40)

1. Chen, B., Arnold, L.L., Cohen, S.M., Thomas, D.J., Le, X.C., Mouse arsenic (+ 3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after Arsenite Administration in Drinking Water. Toxicol. Sci. 124:2 (2011), 320–326.
2. Currier, J.M., Svoboda, M., de Moraes, D.P., Matoušek, T., Dĕdina, J., Stýblo, M., Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping-atomic absorption spectrometry. Chem. Res. Toxicol. 24:4 (2011), 478–480.
3. Currier, J.M., Svoboda, M., Matoušek, T., Dědina, J., Stýblo, M., Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues. Metallomics, 3(12), 2011, 1347.
4. Del Razo, L.M., Styblo, M., Cullen, W.R., Thomas, D.J., Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174:3 (2001), 282–293.
5. Del Razo, L.M., García-Vargas, G.G., Valenzuela, O.L., Castellanos, E., Sánchez-Peña, L.C., Currier, J.M., et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ. Health, 10(1), 2011, 73.
6. Díaz-Villaseñor, A., Sánchez-Soto, M.C., Cebrián, M.E., Ostrosky-Wegman, P., Hiriart, M., Sodium arsenite impairs insulin secretion and transcription in pancreatic β-cells. Toxicol. Appl. Pharmacol. 214:1 (2006), 30–34.
7. Diaz-Villasenor, A., Burns, A., Salazar, A., Sordo, M., Hiriart, M., Cebrian, M., et al. Arsenite reduces insulin secretion in rat pancreatic β-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25. Toxicol. Appl. Pharmacol. 231:3 (2008), 291–299.
8. Ding, L., Saunders, R.J., Drobná, Z., Walton, F.S., Xun, P., Thomas, D.J., et al. Methylation of arsenic by recombinant human wild-type arsenic (+ 3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: role of glutathione. Toxicol. Appl. Pharmacol. 264:1 (2012), 121–130.
9. Douillet, C., Currier, J., Saunders, J., Bodnar, W.M., Matoušek, T., Stýblo, M., Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicol. Appl. Pharmacol. 267:1 (2013), 11–15.
10. Drobna, Z., Jaspers, I., Thomas, D.J., Styblo, M., Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J. 17:1 (2003), 67–69.
11. Drobna, Z., Naranmandura, H., Kubachka, K.M., Edwards, B.C., Herbin-Davis, K., Styblo, M., et al. Disruption of the arsenic (+ 3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22:10 (2009), 1713–1720.
12. Fu, J., Woods, C.G., Yehuda-Shnaidman, E., Zhang, Q., Wong, V., Collins, S., et al. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ. Health Perspect. 118:6 (2010), 864–870.
13. Hernández-Zavala, A., Matoušek, T., Drobná, Z., Paul, D.S., Walton, F., Adair, B.M., et al. Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J. Anal. At. Spectrom. 23:3 (2008), 342–351.
14. Hughes, M.F., Edwards, B.C., Herbin-Davis, K.M., Saunders, J., Styblo, M., Thomas, D.J., Arsenic (+ 3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol. Appl. Pharmacol. 249:3 (2010), 217–223.
15. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, International Agency for Research on Cancer, Some Drinking-Water Disinfectants and Contaminants, Including Arsenic, Vol. 84, 2004, IARC.
16. Lin, S., Del Razo, L.M., Styblo, M., Wang, C., Cullen, W.R., Thomas, D.J., Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14:3 (2001), 305–311.
17. Lin, S., Shi, Q., Nix, F.B., Styblo, M., Beck, M.A., Herbin-Davis, K.M., et al. A NovelS-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277:13 (2002), 10795–10803.
18. Matoušek, T., Hernández-Zavala, A., Svoboda, M., Langrová, L., Adair, B.M., Drobná, Z., et al. Oxidation state specific generation of arsines from methylated arsenicals based on l-cysteine treatment in buffered media for speciation analysis by hydride generation-automated cryotrapping-gas chromatography-atomic absorption spectrometry with the multiatomizer. Spectrochim. Acta B At. Spectrosc. 63:3 (2008), 396–406.
19. Maull, E.A., Ahsan, H., Edwards, J., Longnecker, M.P., Navas-Acien, A., Pi, J., et al. Evaluation of the association between arsenic and diabetes: a National Toxicology Program Workshop Review. Environ. Health Perspect. 120:12 (2012), 1658–1670.
20. Mazumder, D.N., Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 206:2 (2005), 169–175.
21. Naranmandura, H., Rehman, K., Le, X.C., Thomas, D.J., Formation of methylated oxyarsenicals and thioarsenicals in wild-type and arsenic (+ 3 oxidation state) methyltransferase knockout mice exposed to arsenate. Anal. Bioanal. Chem. 405:6 (2012), 1885–1891.
22. Paul, D.S., Harmon, A.W., Devesa, V., Thomas, D.J., Stýblo, M., Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ. Health Perspect. 115:5 (2007), 734–742.
23. Paul, D.S., Hernández-Zavala, A., Walton, F.S., Adair, B.M., Dědina, J., Matoušek, T., et al. Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 222:3 (2007), 305–314.
24. Paul, D.S., Walton, F.S., Saunders, R.J., Stýblo, M., Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ. Health Perspect. 119:8 (2011), 1104–1109.
25. Pi, J., Collins, S., Reactive oxygen species and uncoupling protein 2 in pancreatic β-cell function. Diabetes Obes. Metab. 12 (2010), 141–148.
26. Ren, X., Aleshin, M., Jo, W.J., Dills, R., Kalman, D.A., Vulpe, C.D., Smith, M.T., Zhang, L., Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ. Health Perspect. 119:6 (2011), 771–777.
27. Steffens, A.A., Hong, G.-M., Bain, L.J., Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin. Toxicol. Appl. Pharmacol. 250:2 (2011), 154–161.
28. Thomas, D., Elucidating the pathway for arsenic methylation. Toxicol. Appl. Pharmacol. 198:3 (2004), 319–326.
29. Thomas, D.J., Styblo, M., Lin, S., The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2 (2001), 127–144.
30. Trouba, K.J., Wauson, E.M., Vorce, R.L., Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 PREADIPOCYTES. Toxicol. Appl. Pharmacol. 168:1 (2000), 25–35.
31. Tseng, C.-H., Chong, C.-K., Tseng, C.-P., Centeno, J.A., Blackfoot disease in Taiwan: its link with inorganic arsenic exposure from drinking water. AMBIO J. Human Environ. 36:1 (2007), 82–84.
32. Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G., Cruz-Gonzalez, M.B., Garcia-Montalvo, E.A., Calderon-Aranda, E.S., et al. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113:3 (2004), 250–254.
33. Valenzuela, O.L., Drobná, Z., Hernández-Castellanos, E., Sánchez-Peña, L.C., García-Vargas, G.G., Borja-Aburto, V.H., et al. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239:2 (2009), 200–207.
34. Walton, F.S., Harmon, A.W., Paul, D.S., Drobná, Z., Patel, Y.M., Styblo, M., Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 198:3 (2004), 424–433.
35. Wang, C.-H., Hsiao, C.K., Chen, C.-L., Hsu, L.-I., Chiou, H.-Y., Chen, S.-Y., et al. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol. Appl. Pharmacol. 222:3 (2007), 315–326.
36. Wang, T.-C., Jan, K.-Y., Wang, A.S.S., Gurr, J.-R., Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. Fundam. Mol. Mech. Mutagen. 615:1–2 (2007), 75–86.
37. Wauson, E.M., Langan, A.S., Vorce, R.L., Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicol. Sci. 65:2 (2002), 211–219.
38. Yen, C., Lu, F., Huang, C., Chen, W., Liu, S., Linshiau, S., The diabetogenic effects of the combination of humic acid and arsenic: in vitro and in vivo studies. Toxicol. Lett. 172:3 (2007), 91–105.
39. Yokohira, M., Arnold, L.L., Pennington, K.L., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., et al. Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+ 3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol. Appl. Pharmacol. 246:1–2 (2010), 1–7.
40. Yokohira, M., Arnold, L.L., Pennington, K.L., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., et al. Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+ 3 oxidation state) methyltransferase knockout mice. Toxicol. Sci. 121:2 (2011), 257–266.